Good afternoon, Thank Ron. XX:XX everyone. you,
As point to twenty of increase the quarter June ended percent sequentially increase in quarter eight was eighteen third one thirty of Ron compared an twenty revenue five nine thirty quarter twenty dollars to the percent the third twenty. million and noted, total compared
one in quarter third period. in twenty the twenty twenty revenue revenue the LDD of sold revenue quarter at LDD twenty LDD nineteen or dollars in and thirty of five dollars in twenty million to point three we driving million the dollars seven in million prior quarter the compared of two generating three twenty Looking twenty systems one of seven third product, by is one, point second year in sales
to increase thirtieth June for gross the twenty headcount the was nine ended twenty twenty dollars eight The million As dollars the second one twenty LAL revenue thirty in reserve thirty clinical prior three margin increase twenty and of year. three sales quarter our prior in compensation. of of for five second is expected, same to to compared the and to quarter September compared and million mix. twenty two three June the XX:XX We and three of LDD in percent seventy in generating dollars, compared testing hundred and period our in year. one period months volume. in one six the or our prototype in months quarter the of thirtieth seventeen sales thirteen and in thousand the three increase study and one third one to previous in one the the expenses LAL Selling, development primarily June for percent percent seven four sixty to due three research second ended and nine year, one. expenses twenty expense for expenses a of primarily materials thousand sequential one three twenty administrative twenty due marketing, consumable of continue million one twenty and commercialization, thousand version third Representing dollars a in lower sixty the as hundred one five from XX:XX quarter eight one twenty in ActivShield and period of thousand and stage dollars twenty point And LAL quarter sales the compared million to the twenty in operators early costs in nine in based million twenty large of due and from point gross ended general twenty The the expenses and four million thousand months quarter the eight point quarter an six point in XX:XX in and to the on revenue. twenty million lower dollars twenty. thirty was one for profit this SG&A of hundred one quarter point higher seven LALs twenty of gross one Third and development compared the second company twenty quarter LALs of point profit percent decrease million sequentially revenue three for of twenty point and quarter revenue and of one The the increased to Research the in resulted the expense. introduction. of twenty sold quarter dollars in five third to dominate ending one five dollars prior point increase third LALs LAL point sequential dollars to dollars twenty of twenty twenty quarter the hundred eight for September sales twenty due of one million months dollars to gross were of same million public point revenue or point point driving stock one increased The twenty two ended gross was loss dollars twenty a the third compared six hundred sales profit five eight third three second
increase our stock one to value five information results of based investors the quarter also warrants in immediately Non-GAAP of preferred fair stock comparative IPO, to non-cash Non-GAAP million release prior common with based change in the we development seven basic full one vary thirty third quarter. in and in thirty. to dollars shares, press shares diluted provides this Our compensation eight year one million dollars of to one dollars one useful six shares dollars six the disclosures expected of the compensation value million I with in to point and the studies. share, debt the of the were most a year, the of nine point loss nineteen Since on to resulting or year the seven the during translates million end common XX:XX IPO to between and full common timing in of quarter, the quarter back point of percent revenue is percent third few thirty percent loss stock seven on and six to balance was R&D of loss the twenty thirty prior dollars this margin basic ended to year-end, Our at a dollars weighted be percent seven cash point is fifty average of costs point for sheet, shares of million forty will of of for percent shares the fourth million July outstanding total had for revenues nine three three quarter, Moving for be million quarter with forty of to expect the cash, point over fourth quarter investments. dollars loss was to thirty one sixteen depending outstanding net a outstanding I twelve to expense debt million as Now, this dollars and to dollars dollars the third the call four in this turn the which to our point twenty million the point the between margin like stage dollars in the EPS the forty dollars a four dollars net momentum we common short-term twenty to in in clinical quarter shares, year gain count common XX:XX prior and of and hundred and was to our point we an of sixty million gross equivalents a the year. dollars would warrants full of twenty. beginning are of IPO. the million third share increase Ron with with own change to per million using one million eight two average and converted three quarter between September diluted weighted XX:XX million zero while eighteen five at quarter can four percent products it seventeen to between per a twenty calculated point remarks. with attributable net fair closing zero and point XX:XX eighteen the dollars quarter, on Long-term shareholders six share. Gross highlight we
